Anavex to Present Data on ANAVEX 2-73, Lead Compound for Alzheimer’s Disease, at Japan Neuroscience Society Special Symposium

Hoboken, NJ — September 15, 2011 — Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer’s disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held inYokohama,Japan from September…